ID

39467

Description

The Use of Tolvaptan to Prevent Renal Dysfunction in High Risk Patients With Heart Failure-Pilot Study; ODM derived from: https://clinicaltrials.gov/show/NCT01663662

Lien

https://clinicaltrials.gov/show/NCT01663662

Mots-clés

Versions (1)
  1. 14/01/2020 14/01/2020 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

14 janvier 2020

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Heart Failure NCT01663662

Anglais

Eligibility Heart Failure NCT01663662

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
≥ 18 years old
Description

Age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
prior clinical diagnosis of systolic heart failure (ef < 40% within the past 18 months) with daily home use of oral loop diuretic for at least one month.
Description

Heart Failure, Systolic | Cardiac ejection fraction | Loop Diuretics Oral Daily

Type de données

boolean

Alias
UMLS CUI [1]
C1135191
UMLS CUI [2]
C0232174
UMLS CUI [3,1]
C0354100
UMLS CUI [3,2]
C1527415
UMLS CUI [3,3]
C0332173
daily oral dose of furosemide ≥ 40 mg and ≤ 240 mg (or equivalent)
Description

Furosemide Oral Dose U/day

Type de données

boolean

Alias
UMLS CUI [1,1]
C0016860
UMLS CUI [1,2]
C1527415
UMLS CUI [1,3]
C0178602
UMLS CUI [1,4]
C0456683
identified within 24 hours of hospital admission
Description

Identified | Hospital admission

Type de données

boolean

Alias
UMLS CUI [1]
C0205396
UMLS CUI [2]
C0184666
heart failure defined by at least 1 symptom (dyspnea, orthopnea, or edema) and 1 sign (rales on auscultation, peripheral edema, ascites, pulmonary vascular congestion on chest radiography)
Description

Heart failure | Symptoms Quantity | Dyspnea | Orthopnea | Edema | Sign Quantity | Rales Auscultation | Peripheral edema | Ascites | Pulmonary congestion Vascular Chest X-ray

Type de données

boolean

Alias
UMLS CUI [1]
C0018801
UMLS CUI [2,1]
C1457887
UMLS CUI [2,2]
C1265611
UMLS CUI [3]
C0013404
UMLS CUI [4]
C0085619
UMLS CUI [5]
C0013604
UMLS CUI [6,1]
C0311392
UMLS CUI [6,2]
C1265611
UMLS CUI [7,1]
C0034642
UMLS CUI [7,2]
C0004339
UMLS CUI [8]
C0085649
UMLS CUI [9]
C0003962
UMLS CUI [10,1]
C0242073
UMLS CUI [10,2]
C1801960
UMLS CUI [10,3]
C0039985
anticipated need for iv loop diuretics for at least 48 hours
Description

Patient need for Loop Diuretics Intravenous

Type de données

boolean

Alias
UMLS CUI [1,1]
C0686904
UMLS CUI [1,2]
C0354100
UMLS CUI [1,3]
C1522726
likely requires daily net urine output in the range of 1-3 l/day for over a 72-96 hour time period.
Description

Urine output U/day

Type de données

boolean

Alias
UMLS CUI [1,1]
C0232856
UMLS CUI [1,2]
C0456683
albumin level < 3.5 g/dl
Description

Albumin measurement

Type de données

boolean

Alias
UMLS CUI [1]
C0201838
willingness to provide informed consent
Description

Informed Consent

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
received or planned iv vasoactive treatment (inotropes, vasodilators) or ultra-filtration therapy for heart failure
Description

Vasoactive agent Intravenous Heart failure | Vasoactive agent Intravenous Planned | Inotropic agent | Vasodilator Agents | Ultrafiltration Heart failure

Type de données

boolean

Alias
UMLS CUI [1,1]
C0597639
UMLS CUI [1,2]
C1522726
UMLS CUI [1,3]
C0018801
UMLS CUI [2,1]
C0597639
UMLS CUI [2,2]
C1522726
UMLS CUI [2,3]
C1301732
UMLS CUI [3]
C0304509
UMLS CUI [4]
C0042402
UMLS CUI [5,1]
C0041612
UMLS CUI [5,2]
C0018801
bnp < 250 ng/ml or nt-probnp < 1000 mg/ml (if drawn for clinical purposes)
Description

Brain natriuretic peptide measurement | N-Terminal ProB-type Natriuretic Peptide Measurement

Type de données

boolean

Alias
UMLS CUI [1]
C1095989
UMLS CUI [2]
C3272900
systolic bp < 90 mmhg
Description

Systolic Pressure

Type de données

boolean

Alias
UMLS CUI [1]
C0871470
serum creatinine > 3.0 mg/dl at baseline or renal replacement therapy or creatinine clearances < 10 ml/min
Description

Creatinine measurement, serum | Renal Replacement Therapy | Creatinine clearance measurement

Type de données

boolean

Alias
UMLS CUI [1]
C0201976
UMLS CUI [2]
C0206074
UMLS CUI [3]
C0373595
serum sodium > 145 meq/l
Description

Serum sodium measurement

Type de données

boolean

Alias
UMLS CUI [1]
C0523891
acute coronary syndrome within 4 weeks
Description

Acute Coronary Syndrome

Type de données

boolean

Alias
UMLS CUI [1]
C0948089
anticipated need for coronary angiography or other procedures requiring iv contrast.
Description

Patient need for Coronary angiography | Procedure Requirement Intravenous contrast

Type de données

boolean

Alias
UMLS CUI [1,1]
C0686904
UMLS CUI [1,2]
C0085532
UMLS CUI [2,1]
C0184661
UMLS CUI [2,2]
C1514873
UMLS CUI [2,3]
C4072741
patients receiving any of the following drugs: clarithromycin, ketoconazole, itraconazole,ritonavir, indinavir, nelfinavir, saquinavir, nefazodone, telithromycin, erythromycin, fluconazole, aprepitant, diltiazem, verapamil, cyclosporine, and grapefruit juice.
Description

Clarithromycin | Ketoconazole | Itraconazole | Ritonavir | Indinavir | Nelfinavir | Saquinavir | nefazodone | telithromycin | Erythromycin | Fluconazole | aprepitant | Diltiazem | Verapamil | Cyclosporine | GRAPEFRUIT JUICE

Type de données

boolean

Alias
UMLS CUI [1]
C0055856
UMLS CUI [2]
C0022625
UMLS CUI [3]
C0064113
UMLS CUI [4]
C0292818
UMLS CUI [5]
C0376637
UMLS CUI [6]
C0525005
UMLS CUI [7]
C0286738
UMLS CUI [8]
C0068485
UMLS CUI [9]
C0907410
UMLS CUI [10]
C0014806
UMLS CUI [11]
C0016277
UMLS CUI [12]
C1176306
UMLS CUI [13]
C0012373
UMLS CUI [14]
C0042523
UMLS CUI [15]
C0010592
UMLS CUI [16]
C0452456
pregnant or nursing patients.
Description

Pregnancy | Breast Feeding

Type de données

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
Retour au début de la page

Similar models

Eligibility Heart Failure NCT01663662

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
≥ 18 years old
boolean
C0001779 (UMLS CUI [1])
Heart Failure, Systolic | Cardiac ejection fraction | Loop Diuretics Oral Daily
Item
prior clinical diagnosis of systolic heart failure (ef < 40% within the past 18 months) with daily home use of oral loop diuretic for at least one month.
boolean
C1135191 (UMLS CUI [1])
C0232174 (UMLS CUI [2])
C0354100 (UMLS CUI [3,1])
C1527415 (UMLS CUI [3,2])
C0332173 (UMLS CUI [3,3])
Furosemide Oral Dose U/day
Item
daily oral dose of furosemide ≥ 40 mg and ≤ 240 mg (or equivalent)
boolean
C0016860 (UMLS CUI [1,1])
C1527415 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,3])
C0456683 (UMLS CUI [1,4])
Identified | Hospital admission
Item
identified within 24 hours of hospital admission
boolean
C0205396 (UMLS CUI [1])
C0184666 (UMLS CUI [2])
Heart failure | Symptoms Quantity | Dyspnea | Orthopnea | Edema | Sign Quantity | Rales Auscultation | Peripheral edema | Ascites | Pulmonary congestion Vascular Chest X-ray
Item
heart failure defined by at least 1 symptom (dyspnea, orthopnea, or edema) and 1 sign (rales on auscultation, peripheral edema, ascites, pulmonary vascular congestion on chest radiography)
boolean
C0018801 (UMLS CUI [1])
C1457887 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C0013404 (UMLS CUI [3])
C0085619 (UMLS CUI [4])
C0013604 (UMLS CUI [5])
C0311392 (UMLS CUI [6,1])
C1265611 (UMLS CUI [6,2])
C0034642 (UMLS CUI [7,1])
C0004339 (UMLS CUI [7,2])
C0085649 (UMLS CUI [8])
C0003962 (UMLS CUI [9])
C0242073 (UMLS CUI [10,1])
C1801960 (UMLS CUI [10,2])
C0039985 (UMLS CUI [10,3])
Patient need for Loop Diuretics Intravenous
Item
anticipated need for iv loop diuretics for at least 48 hours
boolean
C0686904 (UMLS CUI [1,1])
C0354100 (UMLS CUI [1,2])
C1522726 (UMLS CUI [1,3])
Urine output U/day
Item
likely requires daily net urine output in the range of 1-3 l/day for over a 72-96 hour time period.
boolean
C0232856 (UMLS CUI [1,1])
C0456683 (UMLS CUI [1,2])
Albumin measurement
Item
albumin level < 3.5 g/dl
boolean
C0201838 (UMLS CUI [1])
Informed Consent
Item
willingness to provide informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Vasoactive agent Intravenous Heart failure | Vasoactive agent Intravenous Planned | Inotropic agent | Vasodilator Agents | Ultrafiltration Heart failure
Item
received or planned iv vasoactive treatment (inotropes, vasodilators) or ultra-filtration therapy for heart failure
boolean
C0597639 (UMLS CUI [1,1])
C1522726 (UMLS CUI [1,2])
C0018801 (UMLS CUI [1,3])
C0597639 (UMLS CUI [2,1])
C1522726 (UMLS CUI [2,2])
C1301732 (UMLS CUI [2,3])
C0304509 (UMLS CUI [3])
C0042402 (UMLS CUI [4])
C0041612 (UMLS CUI [5,1])
C0018801 (UMLS CUI [5,2])
Brain natriuretic peptide measurement | N-Terminal ProB-type Natriuretic Peptide Measurement
Item
bnp < 250 ng/ml or nt-probnp < 1000 mg/ml (if drawn for clinical purposes)
boolean
C1095989 (UMLS CUI [1])
C3272900 (UMLS CUI [2])
Systolic Pressure
Item
systolic bp < 90 mmhg
boolean
C0871470 (UMLS CUI [1])
Creatinine measurement, serum | Renal Replacement Therapy | Creatinine clearance measurement
Item
serum creatinine > 3.0 mg/dl at baseline or renal replacement therapy or creatinine clearances < 10 ml/min
boolean
C0201976 (UMLS CUI [1])
C0206074 (UMLS CUI [2])
C0373595 (UMLS CUI [3])
Serum sodium measurement
Item
serum sodium > 145 meq/l
boolean
C0523891 (UMLS CUI [1])
Acute Coronary Syndrome
Item
acute coronary syndrome within 4 weeks
boolean
C0948089 (UMLS CUI [1])
Patient need for Coronary angiography | Procedure Requirement Intravenous contrast
Item
anticipated need for coronary angiography or other procedures requiring iv contrast.
boolean
C0686904 (UMLS CUI [1,1])
C0085532 (UMLS CUI [1,2])
C0184661 (UMLS CUI [2,1])
C1514873 (UMLS CUI [2,2])
C4072741 (UMLS CUI [2,3])
Clarithromycin | Ketoconazole | Itraconazole | Ritonavir | Indinavir | Nelfinavir | Saquinavir | nefazodone | telithromycin | Erythromycin | Fluconazole | aprepitant | Diltiazem | Verapamil | Cyclosporine | GRAPEFRUIT JUICE
Item
patients receiving any of the following drugs: clarithromycin, ketoconazole, itraconazole,ritonavir, indinavir, nelfinavir, saquinavir, nefazodone, telithromycin, erythromycin, fluconazole, aprepitant, diltiazem, verapamil, cyclosporine, and grapefruit juice.
boolean
C0055856 (UMLS CUI [1])
C0022625 (UMLS CUI [2])
C0064113 (UMLS CUI [3])
C0292818 (UMLS CUI [4])
C0376637 (UMLS CUI [5])
C0525005 (UMLS CUI [6])
C0286738 (UMLS CUI [7])
C0068485 (UMLS CUI [8])
C0907410 (UMLS CUI [9])
C0014806 (UMLS CUI [10])
C0016277 (UMLS CUI [11])
C1176306 (UMLS CUI [12])
C0012373 (UMLS CUI [13])
C0042523 (UMLS CUI [14])
C0010592 (UMLS CUI [15])
C0452456 (UMLS CUI [16])
Pregnancy | Breast Feeding
Item
pregnant or nursing patients.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial